DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 05 · Volume 40 · September 2007 DOI: 10.1055/s-002-7034


25th Symposium of the AGNP
Munich, 3rd–6th October 2007

Chairs: Prof. Dr. W. Wolfgang Fleischhacker, Innsbruck, Dr. Werner Kadus, Karlsruhe
Abstracts (HTML) List of Authors
A001
Beck, J.; Brand, S.; Lehtinen, A.; Hatzinger, M.; Holsboer-Trachsler, E.: Sleep spindle activity in depressed patients is correlated with cognitive performance and predicts treatment outcome
A002
Born, C.; Seitz, N. N.; Grunze, H.; Dittmann, S.; Seemüller, F.; Amann, B.: Are we treating bipolar II disorder insufficient? Preliminary results of a sample of bipolar patients using the prospective NIMH Lifechart-Methodology
A003
Dannlowski, U.; Hetztel, G.; Böckermann, I.; Deckert, J.; Arolt, V.; Rothermundt, M.: Quetiapine in the treatment of agitated depression
A004
Dannlowski, U.; Ohrmann, P.; Konrad, C.; Bauer, J.; Kugel, H.; Schöning, S.; Kersting, A.; Baune, B. T.; Arolt, V.; Heindel, W.; Zwitserlood, P.; Suslow, T.: Reduced amygdala-prefrontal connectivity is associated with symptom severity in major depression
A005
Ditzen, C.; Maccarrone, G.; Uhr, M.; Turck, C. W.: Biomarker discovery in CSF of depressed patients
A006
Dragicevic, A.; Mann, K.; Grasmäder, K.; Verwohlt, P.; Kuss, H. J.; Müller, M. J.; Laux, G.; Rao, M. L.; Röschke, J.; Hiemke, C.: Systematic TDM of antidepressants in psychiatric inpatients under naturalistic conditions
A007
Ebrecht, M.; Foeller, E.; Kungel, M.; Werner, C.; Baker, R.; Pikalov, A.; Modell, S.: Metabolic Syndrome in Patients Enrolled in a Clinical Trial of Aripiprazole in the Maintenance Treatment of Bipolar Disorder
A008
Ebrecht, M.; Marbach, S.; Kungel, M.; Werner, C.; Marcus, R.; McQuade, R.; Modell, S.: Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, placebo- and lithium-controlled study
A009
Ebrecht, M.; Sickmann, T.; Kungel, M.; Werner, C.; Marcus, R.; McQuade, R.; Modell, S.: Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
A010
Seemüller, F.; Riedel, M.; Mayr, A.; Mundt, C.; Holsboer, F.; Marneros, A.; Laux, G.; Bender, W.; Adli, M.; Heuser, I.; Zeiler, J.; Gaebel, W.; Jäger, M.; Möller, H. J.; Henkel, V.: Do data from a large prospective naturalistic study (N=1014, MDD) support the new FDA recommendation concerning antidepressants suicidality risk?
A011
Karoutzou, G.; Chen, J.; Zhang, Y.; Held, K.; Emrich, H. M.; Dietrich, D. E.: Altered electrophysiological parameters of recognition memory in remitted patients with an affective disorder after amantadine treatment
A012
Gerwe, M.; Ibach, B.; Czekalla, J.: A naturalistic study of the effectiveness of oral risperidone (RIS) for the treatment of acute mania (RIS-BIM-0001)
A013
Giegling, I.; Hartmann, A. M.; Schneider, B.; Thalmeier, A.; Schnabel, A.; Maurer, K.; Möller, H. J.; Rujescu, D.: Genetics of aggression-related traits as risk factors for suicidal behavior
A014
Gomez-Carrillo, A.; Neu, P.: Cerebrovascular reactivity in depressed patients without vascular risk factors
A015
Grözinger, M.; Nickl-Jockschat, T.: Recurrent sudden movements resembling startle responses accompany duloxetine treatment
A016
Gruber, O.; Scherk, H.; Zilles, D.; Burke, S.; Gruber, E.; Falkai, P.: Greater gray matter volume in Broca's area in psychiatric patients with preserved verbal working memory – evidence for compensatory neuroplasticity?
A017
Havemann-Reinecke, U.; Brückner, A.; Wedekind, D.; Genee, C.; Hiemke, C.: Factors Affecting the Pharmacokinetics of Escitalopram – Data from a Naturalistic Study
A018
Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S.; Ripke, S.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients
A019
Heck, A.; Lieb, R.; Ellgas, A.; Pfister, H.; Lucae, S.; Erhardt, A.; Himmerich, H.; Horstmann, S.; Kloiber, S.; Ripke, S.; Müller-Myhsok, B.; Bettecken, T.; Uhr, M.; Holsboer, F.; Ising, M.: Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients
A020
Hinze-Selch, D.; Bürger, N. J.; Koch, J. M.; Göder, R.; Aldenhoff, J. B.; Huchzermeier, C.: Changes in cytokine plasma levels during interpersonal psychotherapy (IPT) in unmedicated individuals with major depression: Association with responder status and known confounders
A021
Hinze-Selch, D.; Bürger, N. J.; Koch, J. M.; Göder, R.; Aldenhoff, J. B.; Huchzermeier, C.: Changes in cytokine plasma levels during interpersonal psychotherapy (IPT) in unmedicated individuals with major depression: Association with responder status and known confounders
A022
Chen, J.; Rothermundt, M.; Karoutzou, G.; Zhang, Y.; Ebmeyer, E. C.; Peters, M.; Kirchner, H.; Arolt, V.; Emrich, H. M.; Dietrich, D. E.: Preliminary investigations on immune parameters in remitted patients with an affective disorder after amantadine treatment
A023
Karch, S.; Schiepek, G.; Tominschek, I.; Lutz, J.; Leicht, G.; Born, C.; Mulert, C.; Pogarell, O.: Effect of behavioural therapy on neural substrates of OCD: a single case study
A024
Kiermeir, J.; Linden, M.; Bauer, M.; Stamm, T.; Ricken, R.; Adli, M.: Medical decision making in the treatment of depression – results from the german algorithm project
A025
Kirmeier, T.; Fessler, B.; Wochnik-Veltrup, G.; Kozany, C.; Kimura, M.; Hausch, F.; Uhr, M.; Turck, C.; Holsboer, F.; Rein, T.: Proteomic search for intrcellular binding sites of antidepressants
A026
Kloiber, S.; Ripke, S.; Kohli, M.; Reppermund, S.; Salyakina, D.; Bettecken, T.; Ising, M.; Uhr, M.; Horstmann, S.; Dose, T.; Unschuld, P. G.; Zihl, J.; Müller-Myhsok, B.; Holsboer, F.; Lucae, S.: Polymorphisms in the Leptin Gene are Associated with Resistance to Antidepressant Treatment and Lower Cognitive Performance in Depression
A027
Knobel, A.; Batra, A.; Reimold, M.; Smolka, M. N.; Zimmer, A.; Mann, K.; Solbach, C.; Reischl, G.; Schwärzler, F.; Gründer, G.; Machulla, H. J.; Bares, R.; Heinz, A.: Reduced thalamic serotonin transporter availability in patients with major depression
A028
Koch, J. M.; Goeder, R.; Seeck-Hirschner, M.; Stingele, K.; Aldenhoff, J. B.: Differential effects of serotonergic and noradrenergic antidepressants on cognitive flexibility, sleep and CREB-phosphorylation in depressed patients
A029
Koch, J. M.; Stingele, K.; Seeck-Hirschner, M.; Schulz-Du Bois, A. C.; Aldenhoff, J. B.: CREB-phosphorylation in the course of electroconvulsive therapy (ECT)
A030
Koethe, D.; Llenos, I. C.; Dulay, J. R.; Hoyer, C.; Torrey, E. F.; Weis, S.; Leweke, F. M.: Changes of CB1 cannabinoid receptor expression following Selective Serotonin Reuptake Inhibitors (SSRI) and First Generation Antipsychotics (FGA) in depression and bipolar disorder
A031
Kohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Fey, K.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with age-at-onset of depressive disorder and attempted suicide
A032
Kohli, M. A.; Salyakina, D.; Binder, E. B.; Lucae, S.; Ising, M.; Ripke, S.; Horstmann, S.; Kloiber, S.; Pütz, B.; Lieb, R.; Uhr, M.; Müller, M. B.; Holsboer, F.; Müller-Myhsok, B.: SNPs in the NTRK2 gene are associated with depressive disorder
A033
Kohli, M. A.; Salyakina, D.; Lucae, S.; Ising, M.; Bettecken, T.; Ripke, S.; Uhr, M.; Kloiber, S.; Horstmann, S.; Pütz, B.; Reppermund, S.; Heck, A.; Pfister, H.; Holsboer, F.; Müller-Myhsok, B.: Susceptibility gene hunting for recurrent unipolar depression using 400k genome-wide genotype data
A034
Kronsbein, H. C.; Weber, P.; Refojo, D.; Wurst, W.; Holsboer, F.; Deussing, J. M.: Comparison of gene expression patterns in murine blood and brain after chronic paroxetine treatment
A035
Kundermann, B.; Hemmeter-Spernal, J.; Huber, M. T.; Krieg, J. C.; Lautenbacher, S.: Effects of total sleep deprivation in major depression: Overnight improvement of mood is accompanied by increased pain sensitivity and augmented pain complaints
A036
Leuner, K.; Müller, M.; Kasanzki, V.; Harteneck, C.; Müller, W. E.: Hyperforin mediates neurite outgrowth via TRPC6 channels in PC12 cells
A037
Lucae, S.; Marcus, I.; Saemann, P.; Bettecken, T.; Uhr, M.; Ripke, S.; Kohli, M.; Kloiber, S.; Bondy, B.; Rupprecht, R.; Domschke, K.; Arolt, V.; Lichtner, P.; Holsboer, F.; Müller-Myhsok, B.: Whole genome analysis reveals new potential drug targets as predictors of antidepressant treatment response
A038
Müller, E.; Urmann, I.; Sseruwagi, A.; Künzel, H.; Schuld, A.; Pollmächer, M.: Retrospective and prospective evaluation of therapeutic efficacy of electroconvulsive therapy in patients with depressive disorders in a primary hospital setting
A039
Begemann, M.; Sargin, D.; Rossner, M. J.; Wichert, S. P.; Stender, N.; Fischer, B.; Theis, F.; Bartels, C.; Sperling, S.; Stawicki, S.; Nave, K. A.; Ehrenreich, H.: Phase-specific differential gene expression of peripheral blood mononuclear cells in rapid cycling syndrome
A040
Melcher, T.; Born, C.; Gruber, O.: On the influence of negative affect on the neural mechanisms of cognitive control: an event-related fMRI study
A041
Kluge, M.; Schüssler, P.; Steiger, A.: Duloxetine enhances stage 3 sleep in patients with major depression
A042
Moeller, O.; Evers, S.; Deckert, J.; Baune, B.; Dannlowski, U.; Nguyen, D.; Arolt, V.; Hetzel, G.: The impact of ziprasidone in combination with sertraline on visually-evoked event-related potentials in depressed patients with psychotic features
A043
Muhtz, C.; Wester, M.; Yassouridis, A.; Wiedemann, K.; Kellner, M.: A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD
A044
Murgatroyd, C.; Patchev, A.; Fischer, D.; Almeida, O.; Spengler, D.: Epigenetic Programming of Sustained AVP Expression by Early-Life Stress in Mice
A045
Zill, P.; Baghai, T. C.; Schüle, C.; Eser, D.; Rupprecht, R.; Scheuch, K.; Priller, J.; Walther, D.; Möller, H. J.; Bondy, B.: Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
A046
Pogarell, O.; Koch, W.; Tatsch, K.; Jakob, F.; Mulert, C.; Rupprecht, R.; Möller, H. J.; Padberg, F.: Acute prefrontal rTMS increases striatal dopamine to a similar degree as d-amphetamine
A047
Ricken, R.; Schietsch, K.; Reinhold, T.; Bauer, M.; Adli, M.: Algorithm-guided treatment of depression reduces treatment costs – Results from the German Algorithm Project
A048
Robertson-Plouch, C.; Tohen, M.; Kryshanovskaya, L.; Carlson, G.; DelBello, M.; Wozniak, J.; Kowatch, R.; Wagner, K.; Findling, R.; Lin, D.; Xu, W.; Dittmann, R. W.; Biederman, J.: Olanzapine versus placebo in adolescent mania
A049
Sämann, P. G.; Höhn, D.; Chechko, N.; Kloiber, S.; Lucae, S.; Ising, M.; Holsboer, F.; Czisch, M.: Infralimbic prefrontal cortex structure affects therapy response dynamics in depressive disorder across clinical diagnostic entities
A050
Sämann, P. G.; Höhn, D.; Hemauer, R.; Chechko, N.; Czisch, M.: Doing nothing is different: enhanced subgenual and thalamic participation in acute depression during awake resting
A051
Schielein, T.; Schmid, R.; Spiessl, H.: Psychopharmacotherapy of bipolar affective disorders from an Internet patients' viewpoint
A052
Schommer, N. C.; Schulz-Ratei, B.; Schlattmann, P.; Anghelescu, I.; Heuser, I.: Dexamethasone Suppression Test – a tool for decision making in antidepressive treatment?
A053
Schreier, A.; Wittchen, H. U.; Hoefler, M.; Lieb, R.: Maternal psychopathology – a risk factor for affective, anxiety and substance use disorders in offspring? Results from a prospective-longitudinal community study
A054
Schreier, A.; Wittchen, H. U.; Hoefler, M.; Lieb, R.: Maternal psychopathology – a risk factor for affective, anxiety and substance use disorders in offspring? Results from a prospective-longitudinal community study
A055
Stamm, T. J.; Becker, D.; Kirchheiner, J.; Wiethoff, K.; Bauer, M.; Möller, H. J.; Baghai, T.; Adli, M.: Is the evaluation of early symptom decrease and serum drug levels predictive for response in depressed patients?
A056
Steiner, M.; Marsicano, G.; Nestler, E. J.; Holsboer, F.; Lutz, B.; Wotjak, C. T.: Endocannabinoid signaling modulates HPA axis activity in the mouse – implications for depression disorders
A057
Uebelhack, K.; Franke, L.; Herold, N.; Plotkin, M.; Amthauer, H.; Uebelhack, R.: 123-I-ADAM-SPECT Imaging of Serotonin Transporters in Depressed Patients -Impact of gender to the relationship between SERT and psychopathological symptoms
A058
Unschuld, P. G.; Ising, M.; Erhardt, A.; Lucae, S.; Kohli, M.; Kloiber, S.; Salyakina, D.; Thoeringer, C. K.; Lieb, R.; Uhr, M.; Binder, E. B.; Müller-Myhsok, B.; Holsboer, F.; Keck, M. E.: Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder
A059
Waldschmitt, C.; Vogel, F.; Maurer, C.; Hiemke, C.: Serum concentrations of Duloxetine and Clinical Effects
A060
Wiethoff, K.; Bauer, M.; Baghai, T. C.; Hollinde, D.; Stamm, T.; Möller, H. J.; Adli, M.: Evaluating algorithm-guided treatment for anxious depression in the German Algorithm Project (GAP)
A061
Wochnik, G.; Schuelke, J.; Lang-Rollin, I.; Berning, B.; Rein, T.: Differential effects of TPR proteins on steroid receptor signaling
A062
Wolferstätter, M.; Glasl, L.; Marwedel, A. L.; Bunck, M.; Landgraf, R.; Touma, C.: Linking cognitive abilities and stress reactivity: insights from the HR/IR/LR mouse model
A063
Wittgens, W.; Schreiber, M.: Treatment of affective Symptoms in Geriatric Psychiatry with Pregabalin
A064
Zill, P.; Baghai, T. C.; Schüle, C.; Eser, D.; Scheuch, K.; Priller, J.; Möller, H. J.; Rupprecht, R.; Bondy, B.: Association between SNPs in the promoter region of the tryptophan hydroxylase 2 gene (TPH2) and the hypothalamic-pituitary-adrenocortical (HPA) axis dysregulation in patients with major depression
A065
Zimmermann, P.; Brueckl, T.; Lieb, R.; Ising, M.; Wittchen, H. U.: The interplay of familial depression liability and adverse life events in predicting the first onset of depression during a ten-year follow-up